Top Markets
Coin of the day
Devonian Health Group Inc. Devonian Health Group Inc.

Devonian Health Group Inc.

DVHGF
Classificação em ações #29819
Devonian Health Group Inc. specializes in the creation of botanical-based... Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat conditions such as ulcerative colitis and atopic dermatitis. The company's development pipeline also includes Pantoprazole Magnesium for addressing gastric or duodenal ulcers, Cleo-35 targeting hormonal acne in women, and a range of value-added dermo-cosmetic products. Beyond its own development efforts, Devonian acquires licenses for and distributes various pharmaceutical and health products. Furthermore, the company has established a strategic partnership with CannTx Life Sciences Inc. to collaborate on the development of cannabinoid-based pharmaceutical drugs. Devonian Health Group Inc. was founded in 2015 and is based in Québec, Canada.
Preço da ação
$7.00
Última sincronização: 2026-08-17
Valor de mercado
$19.47M
Variação (1 dia)
0.00%
Variação (1 ano)
-35.19%
País
CA
Negociar Devonian Health Group Inc. (DVHGF)

Categoria

Histórico de preços das ações de Devonian Health Group Inc. (DVHGF)
Preço de fecho mais alto: $7.00 em 2026-08-01

Preço de fecho mais baixo: $35.44 em 2022-09-01
Histórico de preços das ações da Devonian Health Group Inc. de 2022 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 73.19%
2025 -46.13%
2024 -38.22%
2023 -14.47%
2022 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$744.18 7.27%
CH
$1.07K -5.58%
KR